Evidence map›Paper›PMID 32169842›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2020

RNA-Binding Protein HuR Promotes Th17 Cell Differentiation and Can Be Targeted to Reduce Autoimmune Neuroinflammation.

Jing Chen, Jennifer L Martindale, Kotb Abdelmohsen, Gaurav Kumar, Paolo M Fortina, Myriam Gorospe, Abdolmohamad Rostami, Shiguang Yu

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. HuR ablation destabilizesFrontiers in immunology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jing ChenDepartment of Neurology, Thomas Jefferson University, Philadelphia, PA 19107; jing.chen@jefferson.edu shiguang.yu@jefferson.edu.
Jennifer L MartindaleLaboratory of Genetics and Genomics, National Institute on Aging-Intramural Research Program, National Institutes of Health, Baltimore, MD 21224; and.
Kotb AbdelmohsenLaboratory of Genetics and Genomics, National Institute on Aging-Intramural Research Program, National Institutes of Health, Baltimore, MD 21224; and.ORCID 0000-0001-6240-5810
Gaurav KumarDepartment of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107.ORCID 0000-0003-2298-2212
Paolo M FortinaDepartment of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107.ORCID 0000-0002-5898-2081
Myriam GorospeLaboratory of Genetics and Genomics, National Institute on Aging-Intramural Research Program, National Institutes of Health, Baltimore, MD 21224; and.ORCID 0000-0001-5439-3434
Abdolmohamad RostamiDepartment of Neurology, Thomas Jefferson University, Philadelphia, PA 19107.ORCID 0000-0003-0716-2726
Shiguang YuDepartment of Neurology, Thomas Jefferson University, Philadelphia, PA 19107; jing.chen@jefferson.edu shiguang.yu@jefferson.edu.ORCID 0000-0002-7923-3047
Thomas Jefferson University · USNational Institutes of Health · US

Funding

RNA-binding Factors Implicated in Neurogenesis, Alzheimer's Disease, and other Neurodegenerative PathologiesZIAAG000518 · NIA · NATIONAL INSTITUTE ON AGING · PI GOROSPE, MYRIAM · 2009 to 2025
$11.6M
HuR regulates Th17 cells for promoting autoimmune neuroinflammationR01AI119135 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI YU, SHIGUANG · 2015 to 2019
$1.8M
NIAID NIH HHS R01 AI119135
6 · The paper itself

Abstract

Dysregulated Th17 cell differentiation is associated with autoimmune diseases such as multiple sclerosis, which has no curative treatment. Understanding the molecular mechanisms of regulating Th17 cell differentiation will help find a novel therapeutic target for treating Th17 cell-mediated diseases. In this study, we investigated the cell-intrinsic processes by which RNA-binding protein HuR orchestrates Th17 cell fate decisions by posttranscriptionally regulating transcription factors

Indexed as

Cell DifferentiationAnimalsELAV-Like Protein 1Encephalomyelitis, Autoimmune, ExperimentalFemaleFuransInflammationMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicPhenanthrenesQuinonesTh17 Cellsdihydrotanshinone IElavl1 protein, mouseELAV-Like Protein 1FuransPhenanthrenesQuinones

Identifiers

PMID32169842
PMCPMC7534900
OpenAlexW3011245685

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.